This can lead to a reversal of the condition in some patients, offering hope for those with this prevalent liver issue
Novo Nordisk announced plans for legal and regulatory action against Hims, citing patent and safety concerns
A 2019 review in Nutrients examining NAD+ precursor safety in human clinical trials found oral NMN and NR well-tolerated at doses up to 1,000 mg/day with no serious adverse events reported
Look for formulations with proven brightening agents like glutathione, vitamin C, and natural extracts
Fecal microbiota transplantation for irritable bowel syndrome: an intervention for the 21st century
Increasing evidence suggests that microbial communities residing within tumors or at distant mucosal sites can drive resistance to anticancer therapies through diverse mechanisms, including modulation of drug metabolism and transport, induction of ROS, impairment of DDR, activation of oncogenic signaling, and suppression of antitumor immunity